DOI : 10.1097/00005792-197756010-00001

J. Blom, J. Vanderschoot, and M. Oostindi?-er, Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study, Journal of Thrombosis and Haemostasis, vol.18, issue.3, pp.529-564, 2006.
DOI : 10.1056/NEJMoa025313

R. White, H. Chew, and H. Zhou, Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528??693 Adults, Archives of Internal Medicine, vol.165, issue.15, pp.1782-1789, 2005.
DOI : 10.1001/archinte.165.15.1782

A. Alcalay, T. Wun, and V. Khatri, Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on Survival, Journal of Clinical Oncology, vol.24, issue.7, pp.1112-1120, 2006.
DOI : 10.1200/JCO.2005.04.2150

P. Guzm-an-uribe, A. Rosas-l-opez, and J. Zepeda-le-on, Incidence of thrombosis in adults with acute leukemia: a single center experience in Mexico, Rev Investig Cl ?nica Organo Hosp Enfermedades Nutr, vol.65, pp.130-170, 2013.

J. Neoptolemos, D. Stocken, and J. Dunn, Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial, Annals of Surgery, vol.234, issue.6, pp.758-68, 2001.
DOI : 10.1097/00000658-200112000-00007

G. Walker, M. Xenophontos, and L. Chen, Longterm efficacy and safety of exemestane in the treatment of breast cancer, Patient Prefer Adherence, vol.7, pp.245-58, 2013.

H. Sïrensen, L. Mellemkjaer, and J. Olsen, Prognosis of Cancers Associated with Venous Thromboembolism, New England Journal of Medicine, vol.343, issue.25, pp.1846-50, 2000.
DOI : 10.1056/NEJM200012213432504

G. Gasic, P. Koch, and B. Hsu, Der Einflu??? der thrombogenen Aktivit???t von M???usetumoren und menschlichen Tumoren auf Thrombocyten, Blutgerinnung, Fibrinolyse und seine Bedeutung f???r die Metastasierung, Zeitschrift f???r Krebsforschung und Klinische Onkologie, vol.4, issue.3, pp.263-77, 1976.
DOI : 10.1007/BF00286945

E. Sierko and M. Wojtukiewicz, Inhibition of Platelet Function: Does It Offer a Chance of Better Cancer Progression Control?, Seminars in Thrombosis and Hemostasis, vol.33, issue.7, pp.712-733, 2007.
DOI : 10.1055/s-2007-991540

F. Schaffner and W. Ruf, Tissue Factor and PAR2 Signaling in the Tumor Microenvironment, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.12, pp.1999-2004, 2009.
DOI : 10.1161/ATVBAHA.108.177428

P. Winter, The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology, Hematological Oncology, vol.407, issue.3, pp.126-159, 2006.
DOI : 10.1016/S0002-9440(10)64675-5

G. Thomas, L. Panicot-dubois, and R. Lacroix, Cancer cell???derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo, The Journal of Experimental Medicine, vol.327, issue.9, pp.1913-1940, 2009.
DOI : 10.1016/j.critrevonc.2007.01.001

B. Atkinson, R. Jasuja, and V. Chen, Laser-induced endothelial cell activation supports fibrin formation, Blood, vol.116, issue.22, pp.4675-83, 2010.
DOI : 10.1182/blood-2010-05-283986

URL : http://www.bloodjournal.org/content/bloodjournal/116/22/4675.full.pdf

T. Corbett, B. Roberts, and W. Leopold, Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice, Cancer Res, vol.44, pp.717-743, 1984.

L. Panicot-dubois, G. Thomas, and B. Furie, Bile salt???dependent lipase interacts with platelet CXCR4 and modulates thrombus formation in mice and humans, Journal of Clinical Investigation, vol.117, issue.12, pp.3708-3727, 2007.
DOI : 10.1172/JCI32655

URL : http://www.jci.org/articles/view/32655/files/pdf

L. Hubert, R. Darbousset, L. Panicot-dubois, S. Robert, F. Sabatier et al., Neutrophils recruit and activate Human Endothelial Colony Forming Cells at the site of vessel injury via PSGL-1 and L-Selectin, J Thromb Haemost, 2014.

M. Kim, D. Evans, and H. Wang, Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice, Nature Protocols, vol.3, issue.11, pp.1670-80, 2009.
DOI : 10.1093/jnci/djn481

C. Dubois, L. Panicot-dubois, and G. Merrill-skoloff, Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo, Blood, vol.107, issue.10, pp.3902-3908, 2006.
DOI : 10.1182/blood-2005-09-3687

C. Dubois, L. Panicot-dubois, and J. Gainor, Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model, Journal of Clinical Investigation, vol.117, issue.4, pp.953-60, 2007.
DOI : 10.1172/JCI30537

J. Yu, L. May, and V. Lhotak, Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis, Blood, vol.105, issue.4, pp.1734-1775, 2005.
DOI : 10.1182/blood-2004-05-2042

D. Oliveira, A. Lima, L. , M. -. Oliveira, and A. , Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma, Thrombosis Research, vol.130, issue.3, pp.163-170, 2012.
DOI : 10.1016/j.thromres.2012.05.021

R. Darbousset, M. Thomas, and S. Mezouar, Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation, Blood, vol.120, issue.10, pp.2133-2176, 2012.
DOI : 10.1182/blood-2012-06-437772

URL : http://www.bloodjournal.org/content/bloodjournal/120/10/2133.full.pdf

S. Falati, Q. Liu, and P. Gross, Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin, The Journal of Experimental Medicine, vol.267, issue.1, pp.1585-98, 2003.
DOI : 10.1016/0092-8674(93)80055-J

G. Sitia, R. Aiolfi, D. Lucia, and P. , Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B, Proceedings of the National Academy of Sciences, vol.188, issue.2, pp.2165-72, 2012.
DOI : 10.1084/jem.188.2.341

C. Chiodoni, M. Iezzi, and C. Guiducci, Triggering CD40 on endothelial cells contributes to tumor growth, The Journal of Experimental Medicine, vol.96, issue.11, pp.2441-50, 2006.
DOI : 10.1084/jem.20030202

W. Ruf, N. Yokota, and F. Schaffner, Tissue factor in cancer progression and angiogenesis, Thrombosis Research, vol.125, pp.36-38, 2010.
DOI : 10.1016/S0049-3848(10)70010-4

I. Ott, E. Fischer, and Y. Miyagi, A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280, The Journal of Cell Biology, vol.267, issue.5, pp.1241-53, 1998.
DOI : 10.1172/JCI117451

S. Zucker, H. Mirza, and C. Conner, Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferation, International Journal of Cancer, vol.270, issue.5, pp.780-786, 1998.
DOI : 10.1161/01.ATV.15.7.903

D. Carney, G. Herbosa, and J. Stiernberg, Double-Signal Hypothesis for Thrombin Initiation of Cell Proliferation, Seminars in Thrombosis and Hemostasis, vol.12, issue.03, pp.231-271, 1986.
DOI : 10.1055/s-2007-1003559

D. Darmoul, V. Gratio, and H. Devaud, Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer Cells, The American Journal of Pathology, vol.162, issue.5, pp.1503-1516, 2003.
DOI : 10.1016/S0002-9440(10)64283-6

A. Camez, E. Dupuy, and S. Bellucci, Human platelet-tumor cell interactions vary with the tumor cell lines, Invasion Metastasis, vol.6, pp.321-355, 1986.

P. Jurasz, G. Sawicki, and M. Duszyk, Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide, Cancer Res, vol.61, pp.376-82, 2001.

D. Alonso-escolano, A. Strongin, and A. Chung, Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins, British Journal of Pharmacology, vol.275, issue.2, pp.241-52, 2004.
DOI : 10.1074/jbc.275.22.16779

Y. Matsui, H. Amano, and Y. Ito, Thromboxane A2 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells, Cancer Science, vol.27, issue.4, pp.700-707, 2012.
DOI : 10.1007/s10585-010-9311-6

N. Maugeri, D. Fabio, G. Barbanti, and M. , Parnaparin , a low-molecular-weight heparin, prevents P-selectin-dependent formation of plateletleukocyte aggregates in human whole blood, Thromb Haemost, vol.97, pp.965-73, 2007.

P. Rothwell, J. Price, and F. Fowkes, Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials, The Lancet, vol.379, issue.9826, pp.1602-1614, 2012.
DOI : 10.1016/S0140-6736(11)61720-0

P. Rothwell, M. Wilson, and J. Price, Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials, The Lancet, vol.379, issue.9826, pp.1591-601, 2012.
DOI : 10.1016/S0140-6736(12)60209-8

T. St?-urmer, R. Glynn, and I. Lee, Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study, Annals of Internal Medicine, vol.128, issue.9, pp.713-733, 1998.
DOI : 10.7326/0003-4819-128-9-199805010-00003

N. Cook, I. Lee, and J. Gaziano, Low-Dose Aspirin in the Primary Prevention of Cancer, JAMA, vol.294, issue.1, pp.47-55, 2005.
DOI : 10.1001/jama.294.1.47